Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Journal of Forensic Sciences|February 7, 2003
Using resolution calculations to assess changes in capillary electrophoresis run parametersEric Buel, Marcia LaFountain, Margaret SchwartzCancer|December 20, 2011
Pemetrexed in the treatment of relapsed/refractory primary central nervous system lymphomaJeffrey J Raizer, Alfred Rademaker, Andrew M Evens, et al.Frontiers in Oncology|August 28, 2020
Prevention and Management of Dermatologic Adverse Events Associated With Tumor Treating Fields in Patients With GlioblastomaMario E Lacouture, Milan J Anadkat, Matthew T Ballo, et al.CNS Oncology|May 23, 2023
HER2+ esophageal carcinoma leptomeningeal metastases treated with intrathecal trastuzumab regimenScott A Wu, Dan Tong Jia, Margaret Schwartz, et al.BMC Cancer|April 25, 2024
A qualitative evaluation of factors influencing Tumor Treating fields (TTFields) therapy decision making among brain tumor patients and physiciansPriya Kumthekar, Madison Lyleroehr, Leilani Lacson, et al.Blood|November 18, 2022
Determining venous thromboembolism risk in patients with adult-type diffuse gliomaKirsten Bell Burdett, Dusten Unruh, Michael Drumm, et al.Neuro-Oncology|August 10, 2022
A phase I/II study of intrathecal trastuzumab in human epidermal growth factor receptor 2-positive (HER2-positive) cancer with leptomeningeal metastases: Safety, efficacy, and cerebrospinal fluid pharmacokineticsPriya U Kumthekar, Michael J Avram, Andrew B Lassman, et al.Science Translational Medicine|March 11, 2021
A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastomaPriya Kumthekar, Caroline H Ko, Tatjana Paunesku, et al.Pageof 1